Kraft Group leads $6 mln Series A2 round in Silk Therapeutics
Silk Therapeutics, a Boston-based skincare company, raised $6 million in a Series A2 financing round led by returning investor The Kraft Group. New backers Lear Corp and Highland Consumer Partners also participated along with other existing investors. The new round brings Silk Therapeutics’ total Series A funding to $10.25 million.
3 February 2016•4 mins read
